Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia

Betticher, D. C.; Ratschiller, D.; Hsu Schmitz, S.-F.; Von Rohr, A.; Hess, U.; Zulian, G.; Wernli, M.; Tichelli, A.; Tobler, A.; Fey, M. F.; Cerny, T. (1998). Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Annals of oncology, 9(7), pp. 721-726. Oxford University Press 10.1023/A:1008273131598

[img]
Preview
Text
9-7-721.pdf - Published Version
Available under License Publisher holds Copyright.

Download (630kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Betticher, Daniel; Ratschiller, Daniel; Fey, Martin and Cerny, Thomas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Markus Müller

Date Deposited:

01 Oct 2018 15:25

Last Modified:

01 Oct 2018 15:25

Publisher DOI:

10.1023/A:1008273131598

BORIS DOI:

10.7892/boris.115568

URI:

https://boris.unibe.ch/id/eprint/115568

Actions (login required)

Edit item Edit item
Provide Feedback